BioCardia Inc (BCDA)
NASDAQ:BCDA
Holding BCDA?
Track your performance easily

BioCardia (BCDA) Financial Statements

252 Followers

BioCardia Financial Overview

BioCardia's market cap is currently ―. The company's EPS TTM is $-5.329; its P/E ratio is -0.42; BioCardia is scheduled to report earnings on November 13, 2024, and the estimated EPS forecast is $-1.19. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Sep 23Jun 23Mar 23
Income Statement-
Total Revenue$ 3.00K$ 55.00K$ 357.00K$ 43.00K$ 64.00K
Gross Profit$ 3.00K$ 55.00K$ 357.00K$ 43.00K$ 64.00K
EBIT$ -1.65M$ -2.27M$ -2.60M$ -3.42M$ -3.50M
EBITDA$ -1.54M$ -2.16M$ -2.58M$ -3.32M$ -3.40M
Net Income Common Stockholders$ -1.65M$ -2.27M$ -2.57M$ -3.42M$ -3.50M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 1.42M$ 949.00K$ 1.83M$ 4.30M$ 4.86M
Total Assets$ 2.89M$ 2.68M$ 3.75M$ 6.39M$ 7.13M
Total Debt$ 1.14M$ 1.23M$ 1.40M$ 1.48M$ 1.55M
Net Debt$ -283.00K$ 279.00K$ -437.00K$ -2.83M$ -3.30M
Total Liabilities$ 4.85M$ 4.95M$ 4.41M$ 4.75M$ 5.23M
Stockholders Equity$ -1.96M$ -2.27M$ -660.00K$ 1.64M$ 1.90M
Cash Flow-
Free Cash Flow$ -1.31M$ -1.53M$ -2.41M$ -3.15M$ -2.57M
Operating Cash Flow$ -1.31M$ -1.53M$ -2.41M$ -3.15M$ -2.56M
Investing Cash Flow$ -3.00K--$ -2.00K$ -10.00K
Financing Cash Flow$ 1.79M$ 1.38M$ -58.00K$ 2.60M$ 64.00K
Currency in USD

BioCardia Earnings and Revenue History

BioCardia Debt to Assets

BioCardia Cash Flow

BioCardia Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis